We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Cardinal Health
CAH
$55.6B
| $53K | ﹤0.01% |
990
-12
| -1% | -$623 |
|
677
Lockheed Martin
LMT
$139B
| $53K | ﹤0.01% |
149
-197
| -57% | -$72.4K |
|
678
NIO
NIO
$11.9B
| $53K | ﹤0.01% |
1,087
-495
| -31% | -$19.1K |
|
679
Opko Health
OPK
$1.04B
| $51K | ﹤0.01% |
+12,911
| New | +$53.9K |
|
680
Tenaris
TS
$27.2B
| $51K | ﹤0.01% |
+3,197
| New | +$42.6K |
|
|
VIA
681
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $51K | ﹤0.01% |
1,066
-8
| -0.7% | -$370 |
|
682
State Street SPDR S&P Metals & Mining ETF
XME
$4.52B
| $50K | ﹤0.01% |
1,495
+495
| +50% | +$14K |
|
|
CIIC
683
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $49K | ﹤0.01% |
+1,743
| New | +$31.5K |
|
684
BioNTech
BNTX
$23.5B
| $48K | ﹤0.01% |
589
-1,411
| -71% | -$139K |
|
685
Flowserve
FLS
$10.1B
| $48K | ﹤0.01% |
1,303
+3
| +0.2% | +$98 |
|
686
Repligen
RGEN
$9.18B
| $48K | ﹤0.01% |
+250
| New | +$45.5K |
|
687
SLB Ltd
SLB
$77.7B
| $48K | ﹤0.01% |
2,199
-1
| -0% | -$19 |
|
688
Stanley Black & Decker
SWK
$15.4B
| $48K | ﹤0.01% |
+269
| New | +$47.7K |
|
689
AdvisorShares Pure US Cannabis ETF
MSOS
$896M
| $47K | ﹤0.01% |
+1,288
| New | +$38.4K |
|
690
NeoGenomics
NEO
$2.14B
| $47K | ﹤0.01% |
+873
| New | +$39.4K |
|
691
Waste Management
WM
$90.6B
| $47K | ﹤0.01% |
399
-1
| -0.3% | -$117 |
|
|
CWBR
692
DELISTED
CohBar, Inc. Common Stock
CWBR
| $47K | ﹤0.01% |
1,169
+669
| +134% | +$22.6K |
|
693
iShares JPMorgan EM High Yield Bond ETF
EMHY
$636M
| $45K | ﹤0.01% |
971
-2
| -0.2% | -$90 |
|
694
Integra LifeSciences
IART
$1.34B
| $45K | ﹤0.01% |
+693
| New | +$37.3K |
|
695
SL Green Realty
SLG
$3.92B
| $45K | ﹤0.01% |
734
-51
| -6% | -$2.7K |
|
696
Viking Therapeutics
VKTX
$4.03B
| $45K | ﹤0.01% |
7,993
+2,993
| +60% | +$18.1K |
|
|
SI
697
DELISTED
Silvergate Capital Corporation
SI
| $45K | ﹤0.01% |
+606
| New | +$20K |
|
698
Inovio Pharmaceuticals
INO
$72.7M
| $44K | ﹤0.01% |
414
-2,996
| -88% | -$399K |
|
699
Halozyme
HALO
$12B
| $43K | ﹤0.01% |
1,007
-193
| -16% | -$6.94K |
|
700
Qiagen
QGEN
$9.13B
| $43K | ﹤0.01% |
+768
| New | +$41K |
|
Similar funds
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.